GDRX logo

GDRX
GoodRx Holdings Inc

5,945
Mkt Cap
$750.24M
Volume
2.14M
52W High
$5.81
52W Low
$1.77
PE Ratio
26.01
GDRX Fundamentals
Price
$2.19
Prev Close
$2.16
Open
$2.19
50D MA
$2.19
Beta
1.36
Avg. Volume
2.8M
EPS (Annual)
$0.0853
P/B
1.21
Rev/Employee
$1.14M
$1,248.38
Loading...
Loading...
News
all
press releases
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages
GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) has earned an average rating of "Hold" from the fifteen research firms that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recom...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
GoodRx Expands Access to Eli Lilly and Companys New Oral GLP-1, Foundayo, and Zepbound KwikPen with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo (orforglipron). Eligible self-pay patients can access Foundayo through GoodRx at...
Business Wire·2d ago
News Placeholder
Hims & Hers Advances a Consumer-Centric Digital Health Platform
HIMS is broadening its digital-first platform with Labs, hormone therapy and weight-loss programs as it scales personalized care globally.
Zacks·5d ago
News Placeholder
GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update
GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 13th, there was short interest totaling 9,212,055 shares, a...
MarketBeat·13d ago
News Placeholder
HIMS Expands Personalized Digital Healthcare Access and Services
Hims & Hers expands its digital care platform with labs tracking, multi-cancer screening access and broader treatments as it scales personalized healthcare globally.
Zacks·26d ago
News Placeholder
Lakewood Capital Management LP Decreases Position in GoodRx Holdings, Inc. $GDRX
Lakewood Capital Management LP reduced its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 64.1% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·28d ago
News Placeholder
GoodRx (NASDAQ:GDRX) Shares Down 6% - Time to Sell?
GoodRx (NASDAQ:GDRX) Trading Down 6% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced a new collaboration with Viatris, a global healthcare company, to make 17 of its established brand...
Business Wire·1mo ago
News Placeholder
GoodRx to Expand Employer-Sponsored Access to Zepbound KwikPen
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound (tirzepatide) KwikPen (for single-patient-use) through GoodRx...
Business Wire·1mo ago
News Placeholder
Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price
Wells Fargo & Company reduced their price target on shares of GoodRx from $7.00 to $3.50 and set an "overweight" rating on the stock in a research report on Wednesday...
MarketBeat·1mo ago
<
1
2
...
>

Latest GDRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.